MedPath

A clinical study to evaluate the effectiveness of simhayadi kwatha and patoladipanchanga kwatha in the treatment of amlapitta (Gastro esophageal reflex disease)

Phase 2
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Registration Number
CTRI/2024/07/070382
Lead Sponsor
Dr Vijayalakshmi Teggi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subject of either sex.

2. Subject within the age group 18-60 yrs.

3. Subjects with clinical features of Amlapitta such as Avipaka, Klama, Uthklesha, Tikta Amlodgara, Gourava, Hruthkanta daha, and Aruchi will be included.

4. Subjects with controlled systemic disorder such as DM, HTN, etc will be included.

5. Subjects who are willing to give written consents for the study.

Exclusion Criteria

1. Pregnant and Lactating women

2. Subjects with uncontrolled systemic disorder such as Diabetes mellitus, Hypertension, etc

3. Subject diagnosed with Gastro- intestinal disorders like peptic ulcer, pancreatic and hepatic disorders.

4. Subjects with history of haematemesis, malena and other systemic disorders that may interfere with the clinical trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of treatment will be assessed on the basis of changes found in the gradation of the both individual and overall parameters according to their severity before, during and after treatment. <br/ ><br>SUBJECTIVE PARAMETERS <br/ ><br>Avipaka (digestion) <br/ ><br>Klama (tiredness) <br/ ><br>Uthklesha (nausea) <br/ ><br>Tikta amlodgara ( sour and bitter belching) <br/ ><br>Gourava (heaviness of body) <br/ ><br>Hruthkanta daha (burning sensation of throat ) <br/ ><br>Aruchi (anorexia)Timepoint: 30 DAYS
Secondary Outcome Measures
NameTimeMethod
OT APPLICABLETimepoint: NOT APLLICABLE
© Copyright 2025. All Rights Reserved by MedPath